Viewing Study NCT01656304

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:22 PM
Ignite Modification Date: 2026-02-01 @ 12:34 PM
Study NCT ID: NCT01656304
Status: COMPLETED
Last Update Posted: 2018-07-31
First Post: 2012-07-30
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy
Sponsor: Barbara Ann Karmanos Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adenocarcinoma of the Prostate View
None Recurrent Prostate Cancer View
None Stage I Prostate Cancer View
None Stage IIA Prostate Cancer View
None Stage IIB Prostate Cancer View
None Stage III Prostate Cancer View
Keywords: